You searched for nutraceutical | CannIntelligence

22nd Century Group acquires a UK cannabinoid distributor for $650K

Written by Antonia Di Lorenzo | 30th January 2023

US company 22nd Century Group has acquired privately held UK cannabinoid distributor RX Pharmatech for an up-front payment of $650,000 in cash and stock ...

Mergers and acquisitions bringing new cannabis brands to consumers across US

Written by Lorraine Mullaney | 21st December 2022

US cannabis firms have been striking deals to acquire new brands, diversify their offerings and boost production capacity. Recent movers include California’s High Times and Bloomios, while two Oregon firms...

Neptune Wellness joins the exodus from Canada's troubled cannabis market

Written by Lorraine Mullaney | 14th July 2022

Quebec-based Neptune Wellness Solutions has become the latest firm to exit the Canadian cannabis market, switching focus to its consumer packaged goods business, where it sees more potential ...

Incoming Colombian government has big plans for the country’s cannabis industry

Written by CannIntelligence | 8th July 2022

Colombian president-elect Gustavo Petro says he will prioritise development of the nation’s cannabis industry and is promising that he will improve regulation, expand the existing legal framework and clarify production...

UK FSA’s slow-moving novel food authorisation process feeds frustration

Written by CannIntelligence | 20th May 2022

It’s been two years since the deadline for CBD companies to apply for the Food Standards Agency (FSA) novel foods authorisation, yet none have been authorised and few have been...

CBD-Intel's crystal ball reveals possible intoxicating prospects for the year ahead

Written by Freddie Dawson | 29th December 2021

“Intoxicating” will be the word to watch for and THC will be the main driver for developments in 2022, CBD-Intel predicts ...

British Cannabis to manufacture Elixinol for UK and EU after slip-up on novel food

Written by Freddie Dawson | 28th December 2021

Elixinol will continue to be produced for the UK under a licensing agreement with British Cannabis despite having pulled out of the UK and European markets after missing the boat...

Arby Barroso talks about the future of CBD and nutraceuticals on the CBD-Intel podcast

Written by JuditBach | 21st December 2021

CBD-Intel podcast editor Jon Bruford meets Green Roads advocate, Arby Barroso, who talks about the future of CBD and...

Test-tube cannabinoids: scientists seek alternatives to agricultural production

Written by CannIntelligence | 11th August 2021

New methods for laboratory production of cannabinoids show some promise – but it’s still not clear whether they will yield enough to be commercially viable ...

Investor funding drives company growth and increases cannabis research

Written by Lorraine Mullaney | 11th August 2021

New funding raised from investors will propel cannabis company expansion and research ...

UK report says cannabinoids should be under health, not law-and-order rules

Written by Freddie Dawson | 24th June 2021

The British government must take oversight of CBD and medical cannabis out of Home Office hands and place it with the Department of Health and Social Care, according to a...

CBD health and wellness subcategory sees advances on a global scale

Written by Lorraine Mullaney | 5th February 2021

CBD firms are making further advances into the health and wellness subcategory of the market with new product launches, distribution deals, and clinical studies underway ...

CBD drinks – 'a superior option for those traditionally alcohol-driven occasions'

Written by Lorraine Mullaney | 19th January 2021

Health and wellness appear to be the primary marketing position for new cannabinoid beverage launches ...

Wellness trend pushes multiple launches in CBD space

Written by Lorraine Mullaney | 2nd October 2020

Increasing numbers of CBD businesses are marketing products that chime with the wellness trend and now even Playboy is launching a line of CBD products in the US that promise...

US FDA takes action over unapproved drugs and unproven health claims

Written by Freddie Dawson | 29th May 2020

The company behind the world’s first injectable CBD product has issued a voluntary recall, while the US FDA continues to send warning letters over unsubstantiated health claims ...

More CBD companies land in hot water with US FDA over COVID-19 claims

Written by CannIntelligence | 20th April 2020

Companies that have made claims about CBD’s beneficial effects against COVID-19 are facing swift enforcement action from US regulatory authorities ...

CBD-Intel regulatory news in brief, 10th-16th March

Written by CannIntelligence | 16th March 2020

This week's regulatory news in brief brings updates from the EU, Finland, Germany, Italy, the Netherlands, Switzerland, Mexico, the US, Colombia, Israel, Lebanon, Myanmar and Paraguay ...

Law firm leads call for joined-up hemp regulation between US states

Written by CannIntelligence | 5th March 2020

A coalition of organisations linked to the US hemp market has released the first part of a series of policy recommendations – while one CBD firm has been referred to...

Wuhan launches out into South Africa with coffee, creams and mushrooms

Written by CannIntelligence | 16th December 2019

Wuhan General Group has announced that it is to launch CBD cosmetic creams, coffees and medicinal mushrooms in South Africa before a planned expansion across more of the region...

Regulation of CBD in edibles: an international overview

Written by CannIntelligence | 25th November 2019

The CBD industry navigates a complex and changing regulatory landscape across the world, with parts of the industry operating in a grey area. This is particularly the case for one...

CBD-Intel regulatory news in brief, 22nd-28th October

Written by CannIntelligence | 28th October 2019

A hemp shop in Germany has been raided by local authorities, whilst a company in Florida faces warnings for unsubstantiated claims about its products. This, and other news from India...

Hemp banned but enforcement mild: India regulatory report

Written by Marija Obradovic | 11th September 2019

In our look at the regulatory picture in India we find that while CBD is regulated at a federal level, states also have their own rules and regulations with some...

CBD-Intel business news in brief

Written by CannIntelligence | 10th September 2019

From US over-production to European and Chinese expansion plans, via CBD toothpicks, sports star promotions and threatened job losses ...

CBD-Intel business news in brief, 8th-12th July 2019

Written by CannIntelligence | 15th July 2019

CBD-Intel brings you up-to-date with the latest developments in the fast-moving world of CBD business deals ...

Emerald Health prepares to sort the CBD from the chaff

Written by Freddie Dawson | 4th October 2018

Canadian company Emerald Health Therapeutics is set to sign a deal to use an extraction facility capable of processing 1000 tonnes of biomass to produce 600m softgel CBD capsules a...

LATEST ALERTS

Search Results: nutraceutical

Filter by